SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-17-059794
Filing Date
2017-11-16
Accepted
2017-11-16 19:23:11
Documents
1
Period of Report
2017-11-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv479805_4.html 4  
1 OWNERSHIP DOCUMENT tv479805_4.xml 4 4232
  Complete submission text file 0001144204-17-059794.txt   5719
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Issuer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O SORRENTO THERAPEUTICS, INC. 4955 DIRECTOR'S PLACE SAN DIEGO CA 92121
Business Address
Followwill Dorman (Reporting) CIK: 0001717947 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36150 | Film No.: 171209300